Key result
SCN5A variants drive inherited channelopathies and structural heart diseases including Brugada syndrome, LQTS, and DCM.
This paper reviews SCN5A variants, their association with cardiac disorders, and potential therapeutic strategies.
Answers are grounded in this paper and cite their sources.
SCN5A screening may refine diagnosis in channelopathies; leaves open prospective trials of variant-directed therapies.
-related cardiac disorders and the newly developed therapy strategies potentially useful to prevent and treat these disorders in clinical setting.
No takes yet. Share an insight, caveat, or question.
Li et al. (2018) conducted a review in SCN5A-related cardiac disorders. SCN5A variants are causatively associated with various inherited cardiac channelopathies and structural heart diseases, including Brugada syndrome, long QT syndrome, and dilated cardiomyopathy.
Synapse has enriched 10 related papers. Consider them for comparative context: